Epstein Becker Green conducted a health regulatory due diligence review of a national dialysis provider on behalf of a private equity firm investing in health care, including billing and coding compliance and payor relationships, corporate compliance, privacy and security compliance, referral source arrangements, licensing and accreditation, and litigation and government investigations risks.